Cyagen
Cyagen is a contract research organization specializing in custom animal models, cell lines, and viral vector packaging for preclinical research. The company offers genetically engineered rodent models through techniques including TurboKnockout gene targeting, CRISPR-based editing, transgenic generation, and Cre-ESC manipulation. Its product portfolio includes humanized mouse models (HUGO-GT, HUGO-Ab),…
Funding snapshot
About
Cyagen is a contract research organization specializing in custom animal models, cell lines, and viral vector packaging for preclinical research. The company offers genetically engineered rodent models through techniques including TurboKnockout gene targeting, CRISPR-based editing, transgenic generation, and Cre-ESC manipulation. Its product portfolio includes humanized mouse models (HUGO-GT, HUGO-Ab), disease-specific models for oncology, neurology, metabolism, and immunology, as well as custom iPSC, knockout, and knockin cell lines. Cyagen also provides AAV, lentivirus, and adenovirus packaging services for gene therapy and vaccine R&D, along with antibody discovery platforms utilizing fully human antibody mice and AI-powered screening. Founded in 2005 and headquartered in Santa Clara, California, the company has raised approximately $40.5 million in Series B funding from investors including GF Xinde Investment Management, China Merchants Securities, GF Qianhe Investment, and Guanghua Venture Capital.
Business model
Genomics > Genomics Research > Research Models,
Life Sciences Platforms and Tools > Research Services > Animal Models > Xenograft Models > Mouse & Rat Models
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.